OIVD Mission
We work to promote and protect public health through clear and
consistent regulation of in vitro diagnostic devices (IVDs). We
have a dual charge to foster the rapid transfer of good new IVDs
into the medical market while preventing marketing of unsafe or
ineffective devices. We strive to ensure our work is transparent
and allows all stakeholders to obtain the knowledge required to
make informed decisions about the development, production, and use
of IVDs.
OIVD provides timely, comprehensive, and integrated regulatory
oversight for IVDs through our Total Product Life Cycle program
by:
- applying technical and administrative expertise seamlessly
to a continuum of regulatory processes;
- encouraging systematic information flow and feedback between
the CDRH offices and divisions involved in the regulation of IVDs
and using this feedback to improve oversight of the devices before
and after they reach the market;
- maximizing the timeliness of decision-making and staff interaction;
- actualizing the spirit of the least burdensome provisions of
FDA Modernization Act (FDAMA) by expanding the choices available
and simplifying the current methods for defining IVD performance;
and
- developing new methods of postmarket monitoring of IVDs that
produce a more complete picture of IVD device behavior in an everyday
setting.
|